Three-way bladder catheter prototype for bladder washing
10.15343/0104-7809.202246096108
Keywords:
Transurethral Resection of the Prostate. Nursing care. Inventions. Indwelling Catheters. Therapeutic irrigation.Abstract
The main postoperative complications of Transurethral Resection of the Prostate (TURP) are urinary retention by blood clots in the probe and exogenous contamination of the urinary system by manipulation of the healthcare professional when performing the bladder washing technique. The aim of this study was to develop a prototype for keeping the urinary system closed during bladder washes and to measure the internal pressures of the three-way Indwelling Urinary Catheter (IDC) during the bladder washing technique. This was a technological study based on the Rozenfeld's Product Development Process model. Functionality tests were carried out through experiments in a controlled environment in the laboratory. The prototype showed satisfactory results regarding the preservation of the urinary system closed during the bladder washing technique. It was possible to obtain specific pressures from the three-way IDC at three different moments: unobstructed catheter, partially obstructed catheter, and totally obstructed catheter. The results obtained demonstrate that the prototype can represent an innovative tool in the area of urology. It met the project's specifications and preserved the urinary system closed during the bladder washing. Moreover, it reduces the risk of urinary system contamination during the technique manipulation. Therefore, the present study showed that the prototype is fully safe regarding the pressures exerted inside the IDC. There is a need to carry out experimental tests in humans to prove the decrease of urinary tract contamination with the use of this prototype.
Downloads
References
2. Forcellini F. Projeto Integrado de Produtos: planejamento, concepção e modelagem. São Paulo: Manole; 2008.
3. Oliveira GA, Carneiro VF, Martins YM, Castro PR. Prostatectomia e Hernioplastia Laparoscópicas. Rev Urominas [revista em Internet]. 2017; acesso 05 janeiros de 2021. Disponível em: http://urominas.com/wp-content/uploads/2017/10/3- Prostatectomia-e-Hernioplastia.pdf
4. Claro J de A. A experiência bem-sucedida do Centro de Referência da Saúde do Homem no tratamento da hiperplasia benigna da próstata. Boletim do Instituto de Saúde [revista em Internet]. 2012; acesso 10 janeiro 2021. Disponível em: https:// docs.bvsalud.org/biblioref/2020/01/1047347/v14n1-119-126.pdf
5. Diez BL, Montoya RO. Cateterismo Uretral: Um tema para La reflexion. Investigación y Educación en Enfermería [revista em Internet]. 2008; acesso 20 dezembro de 2020. Disponível em: http://www.scielo.org.co/scielo.php?script=sci_ arttext&pid=S0120-53072005000200010
6. Homenko A, Lelis M, Cury J. Verdades e mitos no seguimento de pacientes com cateteres vesicais de demora. Sinopse de urologia. 2003;7(2):35–40.
7. Barboza L, Malafaia O, Slongo L, Meyer F, Nassif P, Tabushi F, et al., Holmium Laser enucleation of the prostate (HoLEP) versus Transurethral Resection of the Prostate (TURP). Rev Col Bras Cir. 2015;42(3):165–170. doi.org/10.1590/0100- 69912015003007
8. Nardozza Júnior A, Zerati Filho M, Borges dos Reis R. Urologia Fundamental. São Paulo: Planmark Editora; 2009.
9. Anthony J Schaeffer. Placement and management of urinary bladder catheters in adults [revista em Internet]. 2021; acesso 03 fevereiro de 2022. Disponível em: https://www.uptodate.com/contents/placement-and-management-of-urinary-bladder-catheters-in-adults?search.
10. Kim E, Larson J, Andriole G. Management of Benign Prostatic Hyperplasia. Annu. Rev. Med. 2016;67;137–51.
11. Rozenfeld H, Forcellini F, Amaral D, Toledo J, Silva S, Alliprandini D, et al. Gestão de Desenvolvimento de Produtos. Uma referência para a melhoria do processo. Rio de Janeiro: Saraiva; 2006.
12. Mebust W, Holtgrewe H, Cockett A, Peters P. Transurethral Prostatectomy: Immediate and Postoperative Complications. A Cooperative Study of 13 Participating Institutions Evaluating 3.885 patients. J Urol. 2002;141(2);243–247. DOI: 10.1016/ s0022-5347(17)40731-2
13. Cristiano M, Gomes F, Rocha T, Marco A. Bladder outlet obstruction and urodynamic evaluation in patients with benign prostatic hyperplasia. Braz J Urol. 2001;27(6):575–88.
14. Wroclawski M. Hiperplasia prostática gigante: hematúria macroscópica com choque hipovolêmico em paciente previamente assintomático. J. Einstein. 2014;3(13):420–422. DOI: 10.1590/S1679-45082015RC2905
15. Mcguire E. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol. 1981;126(2):205–9. DOI: 10.1016/ s0022-5347(17)54449-3
16. Griffiths D, Hofner K, Mastrigt R, Rollema H, Gleason D. Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of PressureFlow Studies. Neurourol Urodyn. 1997: 16(1): 1-18. DOI: 10.1002/(sici)1520- 6777(1997)16:1<1::aid-nau1>3.0.co;2-i
17. McConnell J, Barry M, Bruskewitz R. Benign Prostatic Hyperplasia: Diagnosis and Treatment. Agency for Health Care Policy and Research. Clin Pract Guidel Quick Ref Guide Clin. 1994:2(8):1-17.
18. McLoughlin J, Gill K, Abel P, Williams G. Symptoms versus flow rates versus urodynamics in the selection of patients for prostatectomy. Br J Urol. 1990:66(3):303–305. DOI: 10.1111/j.1464-410x.1990.tb14932.x
19. Filho R, Rocha A, Costa A, Santos F. Hiperplasia prostática benigna: revisão de literatura. Rev Interdiscip. 2018:10(1):200– 204.
20. Nakahira J, Sawai T, Fujiwara A, Minami T. Transurethral resection syndrome in elderly patients: a retrospective observation study. BMC Anesthesio. 2014; 23: 14-30. DOI: 10.1186/1471-2253- 14-30.
21. Rodrigues P, Lucon A, Freire G, Arap S. Urodynamic pressure flow studies can predict the clinical outcome after transurethral prostatic resection. J Urol. 2001;165:499–502. DOI: 10.1097/00005392-200102000-00033
22. Estimativa 2020: Incidência de Câncer no Brasil. Rio de Janeiro: RJ INCA; 2019.
